Skip to content

Clinical trials

Metabolic Diseases trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Phase: Not applicable Country / region: United States Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20091
20102
20116
20125
20133
20141
20151
20167
20174
20189
20192
20202
20218
20224
20238
202411
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Recruiting19
Active, not recruiting6
Not yet recruiting4
Unknown status4
Enrolling by invitation2
Suspended2
Withdrawn2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Michigan5
Massachusetts General Hospital4
Montana State University4
Stanford University4
AdventHealth Translational Research Institute3
Colorado State University3
Brigham and Women's Hospital2
Clinical Nutrition Research Center, Illinois Institute of Technology2
Columbia University2
Fractyl Health Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases88
Obesity29
Diabetes Mellitus21
Insulin Resistance19
Diabetes Mellitus, Type 215
Glucose Metabolism Disorders15
Endocrine System Diseases12
Metabolic Syndrome11
Cardiovascular Diseases10
Inflammation8

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.